These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10335769)

  • 1. Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease.
    Glueck CJ; Lang JE; Tracy T; Sieve-Smith L; Wang P
    Am J Cardiol; 1999 May; 83(10):1490-4, A8. PubMed ID: 10335769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.
    Damoiseaux J; Jeyasekharan AD; Theunissen R; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study.
    Runchey SS; Folsom AR; Tsai MY; Cushman M; McGovern PD
    Br J Haematol; 2002 Dec; 119(4):1005-10. PubMed ID: 12472581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease.
    Puisieux F; de Groote P; Masy E; Di Pompeo C; Millaire A; Bouillanne O; Jude B; Dewailly P; Ducloux G
    Am J Med; 2000 Dec; 109(8):635-41. PubMed ID: 11099683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.
    Adler S; Szczech L; Qureshi A; Bollu R; Thomas-John R
    Clin Nephrol; 2001 Dec; 56(6):428-34. PubMed ID: 11770794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular dementia and anticardiolipin antibodies.
    de Godoy JM; de Godoy MR; Cipulo JP; Tognola VA
    Med Sci Monit; 2005 Sep; 11(9):CR430-3. PubMed ID: 16127362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Clinical and Hematologic Factors Associated with Stenosis and Aneurysm Development in Patients with Atherosclerotic Arterial Disease.
    Park SJ; Kim H; Park JK
    Ann Vasc Surg; 2019 Oct; 60():165-170. PubMed ID: 31195106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin antibodies in rheumatoid arthritis: their relation to rheumatoid nodules and cutaneous vascular manifestations.
    Wolf P; Gretler J; Aglas F; Auer-Grumbach P; Rainer F
    Br J Dermatol; 1994 Jul; 131(1):48-51. PubMed ID: 8043421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus.
    Oger E; Lernyer C; Dueymes M; Le Moigne E; Bressolette L; Escoffre M; Youinou P; Mottier D
    Lupus; 1997; 6(5):455-61. PubMed ID: 9229365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin antibodies in leprosy.
    Thawani G; Bhatia VN; Mukherjee A
    Indian J Lepr; 1994; 66(3):307-14. PubMed ID: 7861045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticardiolipin antibodies in leg ulcers].
    Skare TL; Ribas CA; Malafaia O; Ribas Filho JM; Nassif PA; Nascimento MM; Fonseca VR
    Rev Col Bras Cir; 2009 Apr; 36(2):152-6. PubMed ID: 20076888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticardiolipin antibodies in an unselected stroke population.
    Muir KW; Squire IB; Alwan W; Lees KR
    Lancet; 1994 Aug; 344(8920):452-6. PubMed ID: 7818647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticardiolipin antibodies and osteonecrosis of the femoral head.
    Korompilias AV; Gilkeson GS; Ortel TL; Seaber AV; Urbaniak JR
    Clin Orthop Relat Res; 1997 Dec; (345):174-80. PubMed ID: 9418637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buerger's disease and anticardiolipin antibodies.
    Pereira de Godoy JM; Braile DM
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):792-4. PubMed ID: 19455050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum antiphospholipid antibodies in adults with celiac disease.
    Laine O; Pitkänen K; Lindfors K; Huhtala H; Niemelä O; Collin P; Kurppa K; Kaukinen K
    Dig Liver Dis; 2018 May; 50(5):457-461. PubMed ID: 29258815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk of thrombosis with increased anticardiolipin antibodies].
    Winckelmann G
    Dtsch Med Wochenschr; 1997 Apr; 122(15):492-3. PubMed ID: 9147943
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anticardiolipin antibodies in hemodialysis patients and in renal transplant recipients: prevalence and significance].
    Ferlazzo B; Barrile A; Bonanno D; Quattrocchi P; Santoro D; Savica V; Bellinghieri G
    Recenti Prog Med; 1998 Sep; 89(9):434-7. PubMed ID: 9796372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of lupus anticoagulant and anticardiolipin antibodies in haemodialysis patients.
    Phillips AO; Jones HW; Hambley H; Hillis AN; Hendry BM
    Nephron; 1993; 65(3):350-3. PubMed ID: 8289982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Legg-Calve-Perthes disease and thrombophilia.
    Balasa VV; Gruppo RA; Glueck CJ; Wang P; Roy DR; Wall EJ; Mehlman CT; Crawford AH
    J Bone Joint Surg Am; 2004 Dec; 86(12):2642-7. PubMed ID: 15590848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.